Product NewsDrug discovery > Lead Discovery
FDA Not Currently Planning to Hold Advisory Committee Meeting for Burosumab Biologics License Application
Ultragenyx and Kyowa Hakko Kirin announce regulatory review process proceeding as expected; PDUFA date of April 17, 2018
